Selected publications
John Abraham (forthcoming 2026) Pharmaceuticalization of Society, 250pp. Routledge Book.
John Abraham (forthcoming 2026) Controlling Pharmaceutical Risks: Science, Cancer and the Geneticization of Drug Testing, 295pp. Routledge Book.
John Abraham and Gowree Balendran. (2026) ‘Inside the “Black Box” of Pharmaceuticalisation: NICE, the Permissive Principle and the case of Anti-coagulants’ Sociology of Health & Illness 48 (8), 6 October 2026, pp. 1-14, DOI: 10.1111/1467-9566.70279
John Abraham and Gowree Balendran (2026) ‘Synthetic Certainization in medical controversy: Evidence synthesis, NICE recommendations and the drug-device complex in stroke prevention’ Journal of Critical Public Health 3: 38-56.
Jonathan R. Guillemot, John Abraham and Anthea Tinker (2025) ‘Understanding trends in osteoporosis drug prescribing in England and France’ Frontiers in Medicine (13 January 2025), pp1-17. Doi 10.3389/fmed.2024.1454150
John Abraham and Gowree Balendran (2025) ‘The political sociology of NICE: Investigating pharmaceutical cost-effectiveness regulation in the UK’ Sociology of Health & Illness 47 (1 January 2025), e13878, pp1-14, doi.org/10.1111/1467-9566.13878
John Abraham and Courtney Davis (2020) ‘International and Temporal Comparative Analysis of UK and US Drug Safety Regulation in Changing Political Contexts’ Social Science & Medicine 25 (June): 113005-15.
John Abraham and Courtney Davis (2013) Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science, 348pp. Palgrave Book.
John Abraham and Graham Lewis (2000) Regulating Medicines in Europe: Competition, Expertise and Public Health, 254pp. Routledge Book.
John Abraham (1995) Science, Politics and the Pharmaceutical Industry, 310pp. UCL Press Book.